Systemic AA amyloidosis is a rare complication of benign tumours. This report describes a patient with hepatoceliular adenoma associated with reactive AA amyloidosis. He had a nephrotic syndrome with deteriorating renal function and an increase of serum concentrations of acute phase proteins, mainly Creactive protein. Resection of the tumour was followed by improvement in renal function and a marked decrease ofthe serum concentrations of acute phase proteins.
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AA amyloidosis is usually observed during chronic infectious or inflammatory processes or of malignant neoplasia.' The association of a benign tumour with localised and/or systemic AA amyloidosis has been rarely described.2" We report the case of a man with systemic, mainly renal, AA amyloidosis induced by a liver cell adenoma. Surgical resection of the tumour was followed by an improvement in renal function and a decrease of the serum concentrations of acute phase proteins. hepatomegaly measuring 12 cm on the midclavicular line. Laboratory evaluation disclosed the following: haemoglobin 15 g/dl; white blood cells 8950/41; erythrocyte sedimentation rate 68 mm/h; serum albumin, 26X 1 g/l; serum globulins, 18 g/l; serum fibrinogen 5 -2 g/l; serum C-reactive protein 23-8 mg/l (normal 2-12 mg/l); serum haptoglobin 3.7 g/l (normal 1-3 g/l); blood urea 9.5 mmol/l; serum creatinine 219 [tmol/l; serum alkaline phosphatase 207 IU/l (normal <170); serum yGT, 140 IU/l (normal <20). There was a non-selective proteinuria of 2-1 g/d.
Renal biopsy was performed and histological examination showed amyloid deposits in glomeruli, blood vessels, and to a lesser extent in the interstitium and tubular basal membranes. The birefringence of the deposits was sensitive to permanganate and the AA type of the amyloid substance was confirmed by immunohistochemical analysis using an anti-AA antiserum, as |~~~I . d previously described.7 Ultrasound examination and abdominal computed tomography scan showed a large tumour in the left lobe of the liver (Fig 1) . Ultrasound guided biopsy was performed in the tumour and the right lobe of the liver. Routinely processed samples showed amyloid deposits distorting liver cell plates in the tumour. In the right hepatic lobe, there were only vascular deposits. Amyloid substance was also present in duodenal, colonic and rectal mucosa.
Renal function rapidly deteriorated, and one month after the admission, blood urea and creatinine had reached 13 insufficiency remained stable (urea, 9-9 mmol/l; creatinine, 330 =tmolI1), proteinuria was 34 gld. Biological markers ofinflammation progressively returned to normal ranges: erythrocyte sedimentation rate., 40 mm/h; fibrinogen, 3-2 g/l; haptoglobin, 1F7 g/l; C-reactive protein, 2112mg/I.
Discussion
In this case, the following arguments suggest that AA amyloidosis was induced by the liver cell adenoma: (i) may be raised whether such liver adenomas directly produce SAA or induce, through inflammatory or necrotic changes frequently observed in these tumours,"4 synthesis of SAA under the influence of mediators such as interleukin- 1.15 The first hypothesis is supported by the fact that amyloid deposits were abundant and predominant in the adenoma. Inflammatory processes were probably involved, however, as not only C-reactive protein, but other acute phase proteins, were increased before the surgical procedure and decreased after.
